216 related articles for article (PubMed ID: 19188470)
1. The battle of the clot.
Mandell BF
Cleve Clin J Med; 2009 Feb; 76(2):80. PubMed ID: 19188470
[No Abstract] [Full Text] [Related]
2. Thromboembolism.
Fitzmaurice D; Hobbs FR; McManus R
Clin Evid; 2005 Dec; (14):198-215. PubMed ID: 16620405
[No Abstract] [Full Text] [Related]
3. Thromboembolism.
Fitzmaurice D; Hobbs FD; McManus R
Clin Evid; 2004 Dec; (12):285-308. PubMed ID: 15865639
[No Abstract] [Full Text] [Related]
4. Thromboembolism.
Fitzmaurice D; Hobbs FR; McManus R
Clin Evid; 2003 Dec; (10):273-88. PubMed ID: 15555092
[No Abstract] [Full Text] [Related]
5. Management of thromboembolism in pregnancy.
Marks PW
Semin Perinatol; 2007 Aug; 31(4):227-31. PubMed ID: 17825678
[TBL] [Abstract][Full Text] [Related]
6. Thromboembolism.
Fitzmaurice D; Hobbs FD; McManus R
Clin Evid; 2002 Dec; (8):209-24. PubMed ID: 12603878
[No Abstract] [Full Text] [Related]
7. [Low-molecular-weight heparins].
Ostermann H
Internist (Berl); 1998 Apr; 39(4):414-5. PubMed ID: 9599756
[No Abstract] [Full Text] [Related]
8. Perioperative bridging therapy for the at-risk patient on chronic anticoagulation.
Spyropoulos AC
Dis Mon; 2005; 51(2-3):183-93. PubMed ID: 15900271
[No Abstract] [Full Text] [Related]
9. The treatment of deep venous thrombosis, including the newer agents.
Rectenwald JE; Wakefield TW
Dis Mon; 2005; 51(2-3):104-11. PubMed ID: 15900261
[No Abstract] [Full Text] [Related]
10. Recurrent thromboembolism in ovarian cancer.
Fuglsang J; Ingerslev J; Havsteen H
Acta Obstet Gynecol Scand; 2004 Dec; 83(12):1218-20. PubMed ID: 15548160
[No Abstract] [Full Text] [Related]
11. [Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].
Själander A; Wallentin L; Rosenqvist M; Svensson P
Lakartidningen; 2008 Sep 10-16; 105(37):2478-80. PubMed ID: 19006862
[No Abstract] [Full Text] [Related]
12. New anticoagulants & clinical trials.
Haideri N; Patel H
Mo Med; 2009; 106(1):60-4. PubMed ID: 19245126
[TBL] [Abstract][Full Text] [Related]
13. Perioperative management of warfarin therapy: to bridge or not to bridge, that is the question.
Douketis JD
Mayo Clin Proc; 2008 Jun; 83(6):628-9. PubMed ID: 18533078
[No Abstract] [Full Text] [Related]
14. [Possible effect low molecular weight heparin on survival time. New chances for cancer patients?].
MMW Fortschr Med; 2003 May; 145(19):suppl 3-4. PubMed ID: 12813994
[No Abstract] [Full Text] [Related]
15. A review of the practical advantages of low molecular weight heparin in the treatment of cancer-related venous thromboembolism.
Rhodes S; Bond S
Eur J Oncol Nurs; 2008 Dec; 12(5):425-9. PubMed ID: 18842458
[TBL] [Abstract][Full Text] [Related]
16. Periprocedural bridging management of anticoagulation.
Wysokinski WE; McBane RD
Circulation; 2012 Jul; 126(4):486-90. PubMed ID: 22825410
[No Abstract] [Full Text] [Related]
17. Initiation of warfarin therapy in elderly medical patients: a safe and accurate regimen.
Arsura EL; Bobba RK
Am J Med; 2005 Dec; 118(12):1449-50; author reply 1450. PubMed ID: 16378822
[No Abstract] [Full Text] [Related]
18. Anticoagulant and thrombolytic therapies in women.
Schwartz JB
J Gend Specif Med; 2002; 5(1):14-8. PubMed ID: 11859682
[No Abstract] [Full Text] [Related]
19. Changing paradigms in the management of venous thromboembolism.
Weitz JI
Am Heart Hosp J; 2006; 4(2):135-41. PubMed ID: 16687960
[No Abstract] [Full Text] [Related]
20. Prevention of thromboembolism in pregnancy.
Nelson-Piercy C
Scand J Rheumatol Suppl; 1998; 107():92-6. PubMed ID: 9759142
[No Abstract] [Full Text] [Related]
[Next] [New Search]
